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ABSTRACT: Lowering the modulus of hydrogel particles
could enable them to bypass in vivo physical barriers that
would otherwise filter particles with similar size but higher
modulus. Incorporation of electrolyte moieties into the
polymer network of hydrogel particles to increase the swelling
ratio is a straightforward and quite efficient way to decrease the
modulus. In addition, charged groups in hydrogel particles can
also help secure cargoes. However, the distribution of charged
groups on the surface of a particle can accelerate the clearance
of particles. Herein, we developed a method to synthesize
highly swollen microgels of precise size with near-neutral surface charge while retaining interior charged groups. A strategy was
employed to enable a particle to be highly cross-linked with very small mesh size, and subsequently PEGylated to quench the
exterior amines only without affecting the internal amines. Acidic degradation of the cross-linker allows for swelling of the
particles to microgels with a desired size and deformability. The microgels fabricated demonstrated extended circulation in vivo
compared to their counterparts with a charged surface, and could potentially be utilized in in vivo applications including as oxygen
carriers or nucleic acid scavengers.
■ INTRODUCTION
Hydrogels are promising biomaterials extensively explored in
both tissue engineering and drug delivery because of their
hydrophilicity and biocompatibility.1 When the size of
hydrogels is downscaled to the micro- and nanoregime, the
resulting particles can potentially be engineered for intra-
vascular delivery of therapeutics.2,3 Polyelectrolytes containing
groups such as carboxylic acid or amines are often incorporated
into micro/nanogels not only to swell the particles for easy
permeation of cargos,4,5 but also for securing cargos inside
either through covalent linkage6,7 or electrostatic pairing.8−10
However, distribution of too many charged groups from
polyelectrolytes on the surface of a particle can be a drawback
for intravenous applications, because the charge may cause
nonspecific interaction between the particle and plasma
proteins and elicit recognition by macrophages in the
mononuclear phagocyte system (MPS).11,12 Zeta-potential (ζ-
potential) is generally used to characterize the surface charge of
particles.13 It is known that the higher the absolute value of ζ-
potential, the more a particle tends to interact with macro-
phages.14,15 Cationic particles with a high ζ-potential can also
form aggregates in the presence of the negatively charged
serum proteins once administered intravenously. Such
aggregates can cause emboli in lung capillaries16 and can be
quickly cleared from circulation. To neutralize the surface
charge while still maintaining the colloidal stability of the
particle, decoration of a particle surface with poly(ethylene
glycol) (PEGylation) has been extensively utilized, and proven
to facilitate longer circulation times of intravenously adminis-
tered particles.11,17 Conventional PEGylation of particles either
creates a dense layer of PEG that screens the surface
charges18,19 or quenches the charged groups.20 However,
neither method would work well for highly swollen hydrogel
particles.
Highly swollen micro- and nanogels containing polyelec-
trolytes are attractive because their low modulus can enable
them to navigate filtration mechanisms commonly found in
vivo, resulting in extended blood circulation times as
demonstrated in previous studies.21−23 We used a technology
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called PRINT (particle replication in nonwetting templates) to
fabricate red blood cell (RBC)-like microgels (approximately 6
μm with a disk shape). PRINT is a precision micromolding
technology developed in our group that can generate defined
particles with controlled size, shape and chemistry, and has
been extensively described in past work.24−26 These RBC-like
hydrogel particles containing carboxyl groups (Particle I; ζ-
potential = −18 mV) had a volumetric swelling ratio Q = 30.4,
with a low elastic modulus (E < 10 kPa). These particles are
capable of undergoing 100% strain under physiological
conditions, and demonstrated a significant (ca. 4 day)
elimination half-life in mice.21,22 They could be conjugated
with significant amounts of hemoglobin (molecular weight MW
= 64 kDa) to yield a potential oxygen carrier,7 while similar
particles containing amine groups as opposed to carboxyl
groups may be used to scavenge nucleic acids in vivo.27 A near-
neutral surface charge is desired for both the carboxyl and
amine containing particles toward each application.
The mesh size of a hydrogel is proportional to Q1/3.28 Using
a modified Flory−Rehner theory presented by Peppas,29 we
calculated the mesh size in Particle I to be 26.6 nm (see details
in Supporting Information), which also explained why
hemoglobin (hydrodynamic diameter Dh = 6 nm at pH =
7.430) readily diffused into the interior of Particle I as
confirmed experimentally.7 This large mesh size made it
difficult to apply a PEG layer on the porous surface of Particle I
to screen the surface charge. It is possible to quench the
charged groups through reaction with PEG; however, these
quenching molecules also had access to the interior of Particle
I. Even for carboxyl-reactive PEG with MW of 30 kDa (Dh =
16.6 nm; see calculation in Supporting Information), we found
the PEG molecules scavenged the interior carboxyl groups
(Figure S8).
Herein we present a strategy to generate high-Q microgels
with near-neutral surface charge while retaining charged groups
(primary amines or carboxylic acids) in the interior (Scheme
1). We created highly cross-linked, minimally swollen PRINT
particles containing primary amines (referred to as base Particle
A) first, followed by selectively quenching the surface charge
through PEGylation to generate surface-PEGylated base
Particle B. Then the swelling ratio of Particle B was increased
to produce soft hydrogel particles containing internal cationic
charge (referred to as cationic-interior Particle C). Succinyla-
tion of primary amines in Particle C would convert them into
carboxylic acids, resulting in particles with internal anionic
charge (referred to as anionic-interior Particle D).
■ RESULTS AND DISCUSSION
The key element of our proposed synthetic strategy lies in
minimizing the swelling ratio of particles during quenching of
surface charge while allowing the swelling after quenching. Such
a volumetric transition of particles was realized through the
incorporation of transiently hydrophobic components into
particles. Only after removal of these hydrophobic components
post quenching would the particles swell to the desired extent.
We set out to prepare a selection of acid-labile, hydrophobic
monomers for this purpose as acidic hydrolysis is a simple way
to realize the hydrophobicity-to-hydrophilicity conversion.31−33
The hydroxyl group of the hydrophilic monomer 2-
hydroxyethyl acrylate (HEA) was protected using selected
hydrophobic groups to generate hydrophobic monomers 1−3
as shown in Figure 1a. HEA has proven to be a great monomer
for fabricating low modulus microgels as demonstrated in a
previous study of ours.21 These hydroxyl protecting groups
Scheme 1. Synthetic Route from PRINT Particles to Microgels with Asymmetric Charge Distribution (Particle A to Particle D)a
aControl particles with high surface charges were produced following the route of Particle A to Particle F. The schematic structures of Particle A and
E are shown.
Figure 1. Structures of acid-labile, hydrophobic precursors to HEA in
the form of (a) monomers (1−3) and (b) cross-linkers (4−7).
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were chosen because the cleavage of acetal (in 1, 2) or silyl
ether (in 3) groups can be done in aqueous solution without
requiring harsh conditions. PEG diacrylate (MW = 4000 Da; 2
wt %) was introduced as a permanent cross-linker for the
hydrogel particles. The primary amine-containing monomer, 2-
aminoethyl methacrylate (AEM), was copolymerized into the
particles to provide a positive charge as well as a chemical
handle for the PEGylation reaction. However, even with only
10 wt % AEM in the particle formulation, the resulting particles
from the most hydrophobic monomer 3 still showed Q of 4.9
with an estimated mesh size of 16.2 nm.
Compared to the transient hydrophobic monomers, acid-
labile cross-linkers were found to create densely cross-linked
“tight” particles. Several cross-linkers derived from HEA had
been considered (4−7; Figure 1b),and each of them could
result in minimally swollen particles after the PRINT process.
We opted for 7, an acetal diacrylate (ADA),34−36 because the
cross-linked particles could: 1) degrade quickly at pH = 3 to
swell to the desired size (<3 h, compared to >24 h for 5 and >5
d for 6), shortening workup time; 2) stay minimally swollen
without premature swelling (no obvious swelling in 3 d
compared to Q = 4.1 after 6 h for 4) in phosphate buffered
saline (PBS, pH = 7.4) for storage before further reactions were
carried out.
The formulation for the fabrication of ADA cross-linked
Particle A is shown in Table S1, containing 20 wt % AEM.
Using a PRINT mold with 2 μm-diameter disc-like cavities, we
fabricated Particles A that were 2.3 ± 0.18 μm in diameter
when dispersed in PBS (Figure 2a). The calculated mesh size of
Particle A is only 1.5 nm (Q = 1.5). The size change of Particle
A over time, due to ADA degradation at different pH’s, is
shown in Figure 2c. The particles could swell to a final size of
ca. 5.2 μm (Figure 2b; referred to as control cationic Particle E)
in just 2 h in pH = 3 buffer. Using FTIR (Figure S6), we
confirmed that all of the acetal groups in Particle A could be
degraded within 2 h in pH = 3 buffer.
Such a volumetric transition of hydrogel particles is possible
when the dispersing medium was switched between a poor
solvent for the polymer network to water. Nonpolar organic
solvents can deswell hydrogel particles like Particle I; however,
such an approach also induces severe irreversible aggregation.
In our approach, the swelling of particles could be minimized
without affecting the colloidal stability of particles dispersed in
aqueous media.
To quench the surface charge through PEGylation without
losing internal charged groups, Particle A was PEGylated in the
“tight” state before swelling was allowed. Methoxyl PEG
succinimidyl esters (mPEG-NHS) with different MWs (Table
1) were used to quench the amine groups on Particle A, and we
measured the ζ-potential of the resultant Particle B to evaluate
the efficacy of the quenching. At the same moles of mPEG-
NHS used for the same weighted particles, PEG with higher
MW was more efficient in screening the surface charge as the
corresponding ζ-potential of Particle B became closer to 0 mV
(Table 1). Degradation of ADA in PEGylated Particle B by pH
= 3 buffer for 2 h led to swollen Particle C. However, the ζ-
potential of Particle C showed the opposite trend against MW
compared to Particle B. Therefore, PEGs with higher MW
could shield the charge more efficiently in Particle B, yet were
less efficient in actually quenching the amines because the
larger PEG size limited grafting to the surface of Particle B,
exposing more remaining amines on the surface in Particle C as
demonstrated by a higher ζ-potential. To efficiently quench the
surface amines while minimizing the diffusion of PEG into the
interior of particles, mPEG2k-NHS was used in the following
studies.
Confocal microscopy was used to confirm that PEGylation
using mPEG2k-NHS was limited to the particle surface. This
technique utilized a fluorescent probe, fluorescein-PEG2k-NHS,
to react with a dyeless model particle that was fabricated with
the same composition as Particle A but in a PRINT mold with
larger cavities (7 × 7 × 3 μm cylinder-shaped) for better
visualization. Figure 3a displays a ring-like fluorescence pattern
Figure 2. Fluorescent microscopic image of (a) freshly prepared
Particle A and (b) swollen Particle E after acetal degradation in pH = 3
buffer for 2 h. (c) Size increase of Particle A overtime in different pH’s.
Aliquots of particle suspensions were taken out and resuspended in
PBS for sizing by averaging diameter of particles under microscope (n
= 50).
Table 1. ζ-Potential of Particles B and C When mPEG-NHS
with MW of 2, 5, and 30 kDa Were Used for the PEGylation
under Identical Conditions
MW of mPEG-NHS 2 kDa 5 kDa 30 kDa
ζ-potential (mV) B 2.23 2.12 0.85
C 2.54 4.86 5.27
Figure 3. Confocal microscopic image of model particles (7 × 7 × 3
μm cylinders) after reaction with (a) fluorescein-PEG2k-NHS and (b)
fluorescein-NHS; the line scan insets show relative fluorescent
intensity in particles. The molar stoichiometry of −NHS to particle
was the same in both reactions.
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present at the cross-section of these PEGylated model particles
observed under a confocal microscope, indicating distribution
of fluorescein-PEG2k-NHS only on or close to the particle
surface. In controls where fluorescein-NHS (MW = 473 Da)
was used instead to quench the model particles under the same
conditions, a disc-like fluorescence pattern was shown instead
(Figure 3b). Therefore, we can infer that the quenching
reaction by mPEG2k-NHS was also limited to the surface of
Particle A.
When carboxyl groups are preferred in the interior, the
primary amines in Particle C could be completely converted to
carboxyl groups by succinylation in 10x PBS, generating
Particle D. The size and ζ-potential of the particles at different
stages following the synthetic route from Particle A to D are
summarized in Table 2. The ζ-potential was still close to
neutral for Particle D (−5.80 ± 6.46 mV) after succinylation.
When Particle A was directly degraded without PEGylation
into Particle E, the ζ-potential increased to 28.1 ± 6.49 mV
(Table 2). Succinylation of Particle E reversed the charge to
−32.4 ± 5.26 mV for the anionic particle referred to as control
anionic Particle F. Using a fluorescent assay (see Supporting
Information, Figure S11), we estimated that Particle C had 72%
amine groups as that in Particle E. In contrast, when mPEG2k-
NHS was used to directly quench the high-Q Particle E, only
9.1% of the amines remained when a near-neutral surface
charge was obtained. Therefore, almost 3 quarters of functional
groups in the particles could be preserved using this
constrained quenching method. The richness of amine and
carboxyl groups in the interior of these soft microgels with a
near-neutral surface charge could allow for a higher capacity for
the scavenging of nucleic acids or higher conjugation of protein
into the particles for our intended in vivo applications.
Particles with a high cationic surface are often toxic to
cells.37,38 Indeed, both Particle A and Particle E were found to
be toxic when dosed to human umbilical vein endothelial cells
(HUVECs), as shown in Figure 4a. When all the synthesized
particles were dosed to HUVECs for 24 h with varying
concentrations (from 31.25 to 1000 μg/mL), Particle A
demonstrated toxicity starting at 62.5 μg/mL, while Particle
E showed toxicity starting at 250 μg/mL. Particles B and C,
even though containing cationic charge in the interior, did not
show toxicity up to 1 mg/mL, confirming the effective
quenching of surface amines. Particles D and F were not
toxic as expected.
To assess the effect of the microgel surface characteristics on
their interaction with macrophages, we dosed the same
numbers (see Supporting Information) of different particles
to the Raw 264.7 (mouse leukemic monocyte/macrophage)
cell line. After incubation for 4 and 24 h, the percentage of
macrophages that were associated with particles was measured
by flow cytometry (Figure 4b). Particles with quenched surfaces
(Particles B, C, D) all showed much lower association with the
macrophages than the starting cationic Particle A and
unquenched particles (Particles E, F), indicating reduced
interaction between quenched particles and macrophages.
To compare the in vivo performance of all of the RBC-sized
soft particles, an intravital microscopic imaging method was
used to observe the particles when intravenously injected into
Balb/c mice. Intravital microscopy (IVM) has been used to
assay the accumulation of targeted particles in tumors39 and
tissues;40 it has also been proven to be a reliable method to
evaluate the circulation times of both micro- and nanoparticles
in our previous studies.21,41,42 A near-IR (NIR) dye, DyLight
680, was copolymerized into all of the particle sets; we
observed the peripheral vasculature through the skin of an
anesthetized mouse’s ear to track the NIR fluorescence of
injected particles every 5 s for 2 h (Figure 5a). Elimination
curves were generated by plotting the change in fluorescent
signal from the particles over time normalizing each scan to the
maximum intensity slice (Figure 5b). The mice were sacrificed
after the 2 h scan and the organs were harvested for imaging to
understand the distribution of the particles, expressed by
percent of recovered fluorescence per gram of tissue as shown
in Figure 6a.
As anticipated, particles with a quenched surface showed
extended circulation times over their unquenched controls.
Particle D demonstrated the longest circulation time of all the
particles tested (Figure 5b). After 2 h, Particle D was highly
concentrated in the spleen (Figure 6a), which is characteristic
of highly deformable particles of this size (Particle I; Figure
S14).22 Particle I, which had a moderate negative surface charge
(ζ-potential = −18 mV), demonstrated a very long circulation
Table 2. Summary of Diameter and ζ-Potential of Particles
(mPEG2k-NHS Used for PEGylation Involved)
particle diameter (μm) ζ-potential (mV)
A 2.3 ± 0.18 22.8 ± 6.01
B 2.4 ± 0.22 2.23 ± 4.37
C 5.2 ± 0.33 2.54 ± 4.94
D 5.6 ± 0.29 −5.80 ± 6.46
E 5.2 ± 0.27 28.1 ± 6.49
F 5.7 ± 0.25 −32.4 ± 5.26 Figure 4. (a) Cytotoxicity of different particles after incubation with
HUVECs for 24 h as tested by MTS assay. (n = 3 for each dose; each
data point represented by mean ± SD). (b) Macrophage interaction
with different particles. About 400 particles/cell dosed to a total of 105
Raw264.7 cells for each particle type. (Two-sided unpaired t test done
among selected particles for 4 or 24 h, respectively. ***P < 0.001).
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time characterized by a distribution half-life αt1/2 of 0.6 h, and a
clearance half-life βt1/2 of 85.5 h calculated from conventional
blood-draw method over 120 h.22 In a 2 h scan of intravital
microscopy, the circulation of Particle I (Figure 5b) was
outperformed by Particle D. Therefore, it stands to infer an
even longer circulation time for Particle D than that for Particle
I, even though we could not calculate the half-lives from the
clearance curve obtained from intravital microscopy because
Particle D was probably still within the distribution phase
during the 2 h scan.21,41
Negatively charged Particle F had a very similar biodis-
tribution to Particle D (Figure 6a) and Particle I (Figure S14;
the faster decrease in concentration than Particle D and I was
probably because of clearance by the MPS system since it is
known that higher charged particles attract macrophages
more.14,15 Positively charged Particle E was instantly removed
from circulation (Figure 5a), and most of the particles ended up
in the lung (Figure 6a). Since the lung is the first downstream
tissue with microvasculature post injection, we could speculate
that most of the dose sequestered immediately after injection of
E because of aggregation, which is confirmed by histology of
the lung (Figure 6b). Neutralizing the cationic surface charge
made Particle C capable of circulating (Figure 5a). The bulk of
the dose of Particle C was able to traverse the lung post
injection in contrast to Particle E (Figure 6a, ). Compared to
the carboxyl-containing particles, the clearance rate of Particle
C was fast (Figure 5b). The high porosity in Particle C might
have allowed plasma molecules to gradually infiltrate into the
particles, leading to recognition of Particle C by the MPS
system.
■ CONCLUSION
To summarize, utilizing the method of PEGylation on
transiently minimally swollen particles described herein, we
were able to obtain highly swollen microgels with a neutral
surface charge while retaining charged groups (carboxylic acid
or primary amine) in the interior. Direct PEGylation to
neutralize surface charge of highly swollen microgels otherwise
results in severe loss of the internal charged groups, which were
desired to keep intact in order to efficiently bind cargo. These
uniquely modified particles demonstrated longer circulation
than their counterparts with a charged surface. The key of this
strategy lies in the efficient quenching of the surface charge on
“tight” particles involving a high cross-linking density using a
degradable cross-linker. Even though such a volume transition
was also possible through using polymers bearing a lower
critical solution temperature (LCST) such as poly(N-
isopropylacrylamide),43 these polymers would generally stay
in a collapsed state at body temperature, resulting in rigid
particles. This PEGylation strategy may also be applied to other
nanogel systems in which the tightness and degradation rate
may be tailored by utilizing different degradable cross-linkers to
achieve a balance.
Figure 5. (a) Intravital microscopy images of mouse earlobe blood
vasculature imaged at the rhodamine (Rh) channel by injecting
dextran70k-rhodamine prior to dosing particles, and imaged at the NIR
channel just 100 s after dosing Particle C or Particle E. Scale bars =
100 μm. (b) Decrease in fluorescence of area of interest within 2 h of
imaging by IVM (average of n = 3; mean ± SD shown every 1 min).
For each particle type, 107 particles/g body weight were dosed.
Figure 6. (a) Biodistribution of RBC-sized particles into various
tissues 2 h post dosing by percent fluorescence normalized for tissue
weight, with n = 3 for each case. (Two-sided unpaired t test done
among selected groups. ***P < 0.001; *P < 0.05; ns, not significant.)
(b) Fluorescent images of lung with nucleus stained by DAPI for mice
injected with different particles (shown in purple from NIR dye). All
scale bars = 20 μm.
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